Oncology Clinical Trials in Spokane, WA
As of July 2026, 60 paid clinical trials are recruiting for Oncology in Spokane, Washington. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
60 clinical trials for Oncology
·Clear filters·↓ Download CSVA Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
A Study of YL201 in Patients With Advanced Solid Tumors
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
About research studies in Spokane
Spokane has approximately 222 recruiting research studies across a wide range of therapeutic areas. Washington hosts Fred Hutchinson Cancer Center, UW Medicine, and Seattle Children's — widely recognized for leadership in bone marrow transplantation, immunotherapy, and infectious disease research.
Top Research Study Locations in Spokane
Researchers run research studies in Spokane, WA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Sacred Heart Medical Center and Children's Hospital | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm | 31 |
| Cancer Care Northwest - Spokane South | Breast Cancer, Malignant Solid Neoplasm, Ovarian Carcinoma | 26 |
| Cancer Care Northwest-North Spokane | Breast Cancer, Malignant Solid Neoplasm, Ovarian Carcinoma | 26 |
| Cancer Care Northwest-Valley | Breast Cancer, Malignant Solid Neoplasm, Ovarian Carcinoma | 24 |
| MultiCare Deaconess Cancer and Blood Specialty Center - Downtown | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Childhood Extracranial Germ Cell Tumor | 9 |
| Spokane Eye Clinical Research | Amblyopia, Age-Related Macular Degeneration, Age-related Macular Degeneration (AMD) | 9 |
| MultiCare Deaconess Cancer and Blood Specialty Center - North | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Childhood Extracranial Germ Cell Tumor | 8 |
| Cancer Care Northwest | Advanced/Metastatic Solid Tumors, CRC (Colorectal Cancer), Cancer | 7 |
| Providence Sacred Heart Medical Center | Alport Syndrome, Central Line Associated Blood Stream Infections (CLABSI), Cirrhosis | 6 |
| Inland Northwest Research | Parkinson Disease, Parkinson's Disease, Deep Brain Stimulation | 5 |
| Spokane Urology | Non-Muscle Invasive Bladder Neoplasms, High-Risk Non-Muscle-Invasive Bladder Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 5 |
| Summit Cancer Centers | Adenoid Cystic Carcinoma, Advanced Metastatic Castration Resistant Prostate Cancer, Advanced Solid Tumor | 5 |
| Dermatology Specialists of Spokane | Alopecia Areata (AA), Atopic Dermatitis, Hidradenitis Suppurativa (HS) | 5 |
| Providence Medical Research Center | Bronchiectasis, Chronic Kidney Disease, Glomerulosclerosis, Focal Segmental | 4 |
| Providence Sacred Heart Medical Center & Children's Hospital | Fallopian Tube Cancer, Endometrioid Ovarian Cancer, Epithelial Ovarian Cancer | 4 |
| Washington State University College of Pharmacy and Pharmaceutical Sciences | Interaction, Herbal Interaction | 4 |
| Medical Oncology Associates | Triple Negative Breast Cancer, Castration-resistant Prostate Cancer, Colorectal Cancer | 4 |
| Premier Clinical Research | Actinic Keratosis, Plaque Psoriasis, Hidradenitis Suppurativa | 4 |
| Clinical Trial Site | Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer | 2 |
| Arthritis Northwest | Acute Gout Flare, Arthritis, Gout | 2 |
| Kingfisher Cooperative | Alzheimer Disease, Cervical Dystonia | 2 |
| Providence Medical Group, Cystic Fibrosis Clinic | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 2 |
| Sleep and Performance Research Center | Cataplexy, Circadian Misalignment, Circadian Rhythm | 2 |
| Spokane Joint Replacement Center | Osteoarthritis, Symptomatic Venous Thromboembolism (VTE) | 2 |
| Spokane VA Medical Center, Spokane, WA | Comorbid Post-Traumatic Stress Disorder and OCD, Diabetic Foot, Obsessive Compulsive Disorder (OCD) | 2 |
Active & Upcoming Studies in Spokane (2026)
Recruiting trials in Spokane grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (94 active studies)
- A Study of ARC-02 in B-cell NHL · Phase 1 · Taiho Oncology, Inc.
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · Phase 3 · Children's Oncology Group
Neurology & pain (10 active studies)
- A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · Bristol-Myers Squibb
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
Diabetes & metabolic (8 active studies)
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity · Phase 3 · Amgen
- Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease · Phase 3 · Alessandro Doria
Eye & vision (8 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy · Phase 3 · Regeneron Pharmaceuticals
Cardiovascular (5 active studies)
Pediatric (1 active study)
- NEPTUNE Match Study · University of Michigan
Common conditions studied in Spokane
- Breast Cancer (6 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Head and Neck Squamous Cell Carcinoma (6 active studies). Recruiting Head and Neck Squamous Cell Carcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Malignant Solid Neoplasm (5 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Myeloid Leukemia (4 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Chronic Lymphocytic Leukemia (4 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Fallopian Tube Cancer (4 active studies). Recruiting Fallopian Tube Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Spokane
- Children's Oncology Group
- National Cancer Institute (NCI)
- Washington State University
- AstraZeneca
- SWOG Cancer Research Network
Local regulations and guidelines
Clinical trials in Washington are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Studies in Washington must also comply with the My Health My Data Act, which adds consumer-health-data protections on top of federal HIPAA requirements.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Spokane. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Spokane
Hipa.ai aggregates every recruiting study in Spokane from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Spokane?
There are approximately 222 recruiting clinical trials in Spokane, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Spokane pay participants?
Most recruiting trials in Spokane compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Spokane?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Spokane?
The most common conditions under active study in Spokane include Breast Cancer (6), Head and Neck Squamous Cell Carcinoma (6), Malignant Solid Neoplasm (5), Acute Myeloid Leukemia (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Spokane?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Spokane on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Spokane?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Spokane?
Recruiting research sites in Spokane include Providence Sacred Heart Medical Center and Children's Hospital, Cancer Care Northwest - Spokane South, Cancer Care Northwest-North Spokane, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Spokane right now?
The largest active categories in Spokane are Cancer & tumors (94), Neurology & pain (10), Diabetes & metabolic (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.